386 related articles for article (PubMed ID: 8159307)
1. Complement activation during CAPD.
Young GA; Kendall S; Brownjohn AM
Nephrol Dial Transplant; 1993; 8(12):1372-5. PubMed ID: 8159307
[TBL] [Abstract][Full Text] [Related]
2. Complement activation in platelet concentrates is surface-dependent and modulated by the platelets.
Gyongyossy-Issa MI; McLeod E; Devine DV
J Lab Clin Med; 1994 Jun; 123(6):859-68. PubMed ID: 8201264
[TBL] [Abstract][Full Text] [Related]
3. The analysis of the complement activation product SC5 b-9 is applicable in neonates in spite of their profound C9 deficiency.
Høgåsen AK; Overlie I; Hansen TW; Abrahamsen TG; Finne PH; Høgåsen K
J Perinat Med; 2000; 28(1):39-48. PubMed ID: 10765513
[TBL] [Abstract][Full Text] [Related]
4. Pattern of C3, iC3b, and C3d in patients hospitalized for acute asthma.
Lin RY; Caveliere LF; Lorenzana FG; Go EF; Altman KA
Ann Allergy; 1992 Apr; 68(4):324-30. PubMed ID: 1558328
[TBL] [Abstract][Full Text] [Related]
5. Alterations in C3, C4, factor B, and related metabolites in septic shock.
Lin RY; Astiz ME; Saxon JC; Saha DC; Rackow EC
Clin Immunol Immunopathol; 1993 Nov; 69(2):136-42. PubMed ID: 8403550
[TBL] [Abstract][Full Text] [Related]
6. Activation of classical pathway complement in chronic inflammation. Elevated levels of circulating C3d and C4d split products in rheumatoid arthritis and Crohn's disease.
Petersen NE; Elmgreen J; Teisner B; Svehag SE
Acta Med Scand; 1988; 223(6):557-60. PubMed ID: 3389208
[TBL] [Abstract][Full Text] [Related]
7. [Changes in complement breakdown products and terminal complement complex in patients with acute glomerulonephritis].
Kojima H; Ohi H; Seki M; Hatano M
Nihon Jinzo Gakkai Shi; 1989 Sep; 31(9):925-31. PubMed ID: 2585834
[TBL] [Abstract][Full Text] [Related]
8. Complement abnormalities during an epidemic of group B meningococcal infection in children.
Beatty DW; Ryder CR; Heese HD
Clin Exp Immunol; 1986 Jun; 64(3):465-70. PubMed ID: 3491693
[TBL] [Abstract][Full Text] [Related]
9. Complement components and their activation products in pleural fluid.
Salomaa ER; Viander M; Saaresranta T; Terho EO
Chest; 1998 Sep; 114(3):723-30. PubMed ID: 9743157
[TBL] [Abstract][Full Text] [Related]
10. Complexes between C1q and C3 or C4: novel and specific markers for classical complement pathway activation.
Wouters D; Wiessenberg HD; Hart M; Bruins P; Voskuyl A; Daha MR; Hack CE
J Immunol Methods; 2005 Mar; 298(1-2):35-45. PubMed ID: 15847795
[TBL] [Abstract][Full Text] [Related]
11. Generation of the membrane attack complex during haemodialysis: impact of classical and alternative pathway components.
Hauser AC; Derfler K; Stockenhuber F; Janata O; Balcke P
Clin Sci (Lond); 1990 Nov; 79(5):471-6. PubMed ID: 2174314
[TBL] [Abstract][Full Text] [Related]
12. Complement activation in severe Plasmodium falciparum malaria.
Wenisch C; Spitzauer S; Florris-Linau K; Rumpold H; Vannaphan S; Parschalk B; Graninger W; Looareesuwan S
Clin Immunol Immunopathol; 1997 Nov; 85(2):166-71. PubMed ID: 9344699
[TBL] [Abstract][Full Text] [Related]
13. Complement alterations in inflammatory bowel disease.
Lake AM; Stitzel AE; Urmson JR; Walker WA; Spitzer RE
Gastroenterology; 1979 Jun; 76(6):1374-9. PubMed ID: 437435
[TBL] [Abstract][Full Text] [Related]
14. [Activation of complement by hemodialysis membrane].
Kojima H; Ohi H; Seki M; Sakamoto K; Hatano M; Sudou S; Sudou Y
Nihon Jinzo Gakkai Shi; 1989 Jan; 31(1):91-7. PubMed ID: 2747003
[TBL] [Abstract][Full Text] [Related]
15. Response of the alternative complement pathway to an oral fat load in first-degree relatives of subjects with type II diabetes.
Peake PW; Kriketos AD; Campbell LV; Charlesworth JA
Int J Obes (Lond); 2005 Apr; 29(4):429-35. PubMed ID: 15111984
[TBL] [Abstract][Full Text] [Related]
16. Levels of complement components iC3b, C3c, C4, and SC5b-9 in peritoneal fluid and serum of infertile women with endometriosis.
Kabut J; Kondera-Anasz Z; Sikora J; Mielczarek-Palacz A
Fertil Steril; 2007 Nov; 88(5):1298-303. PubMed ID: 17482181
[TBL] [Abstract][Full Text] [Related]
17. The terminal complement complex (sC5b-9) is not specifically associated with the development of the adult respiratory distress syndrome.
Parsons PE; Giclas PC
Am Rev Respir Dis; 1990 Jan; 141(1):98-103. PubMed ID: 2297192
[TBL] [Abstract][Full Text] [Related]
18. SC5b-9 is the most sensitive marker in assessing disease activity in Brazilian SLE patients.
Chiu YY; Nisihara RM; Würzner R; Kirschfink M; de Messias-Reason IJ
J Investig Allergol Clin Immunol; 1998; 8(4):239-44. PubMed ID: 9777539
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of complement activation between tuberculous and malignant pleuritis].
Hidaka K; Abe M; Tanaka T; Mitsuyama T; Hara N; Hara N
Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Apr; 33(4):379-83. PubMed ID: 7791265
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of plasma SC5b-9 (SMAC) in patients with ARDS].
Hara N; Abe M; Kawarada Y; Inuzuka S; Takahashi H; Goya T; Shigematsu N; Fujita T
Nihon Kyobu Shikkan Gakkai Zasshi; 1992 May; 30(5):796-801. PubMed ID: 1630043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
